Results 151 to 160 of about 99,805 (324)
Pharmacy services and role development in UK general practice: a cross‐sectional survey
International Journal of Pharmacy Practice, EarlyView., 2020 Abstract Background The ‘Clinical Pharmacists in General Practice’ (CPGP) pilot provided a template for general practice pharmacy professionals’ (GPPPs) roles encouraging NHS England to fund >2000 practice‐based pharmacists. However, many GPPPs work outside the CPGP initiative and little is known about the services they provide.
Vilius Savickas +5 more
wiley +1 more source
Therapeutic Advances in Drug SafetyBackground: Polypharmacy is a growing phenomenon among elderly individuals. However, there is little information about the frequency of polypharmacy among the elderly population treated in emergency departments (EDs) and its prognostic effect. This study
Jesus Ruiz Ramos +26 more
doaj +1 more source
Intensification of polypharmacy glucose-lowering treatment in type-2 diabetes: When to be cautious? [PDF]
, 2012 B Charbonnel
openalex +1 more source
Network medicine and systems pharmacology approaches to predicting adverse drug effects
British Journal of Pharmacology, EarlyView.Identifying and understanding the relationships between drug intake and adverse effects that can occur due to inadvertent molecular interactions between drugs and targets is a difficult task, especially considering the numerous variables that can influence the onset of such events.
Alessio Funari +2 more
wiley +1 more source
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.Summary Background and Objectives Hidradenitis suppurativa (HS) is a chronic, debilitating skin disease affecting approximately 0.1% of the German population. Patients with HS require substantial healthcare resource utilization. This study aimed to assess the economic burden associated with HS in Germany.
Falk G. Bechara +7 more
wiley +1 more source
I79. Managing Comorbidities and the Challenge of Polypharmacy in Older Adults with Musculoskeletal Conditions [PDF]
, 2015 Adrian Jones
openalex +1 more source
Diabetes, Obesity and Metabolism, EarlyView.Abstract Aims Clinical guidelines recommend sodium‐glucose cotransporter‐2 inhibitors (SGLT2is) for individuals with type 2 diabetes mellitus (T2DM) and established or high risk of cardiorenal disease. This study examined real‐world SGLT2i use patterns among older adults with T2DM in British Columbia, Canada.
Hanin Harbi +10 more
wiley +1 more source
BMC GeriatricsBackground Polypharmacy is a global public health concern. This study aimed to determine the prevalence of polypharmacy and trends in the use of commonly used and potentially inappropriate medications among older Korean patients. Methods Individuals aged
Woo-young Shin, Tae-Hwa Go, Jung-ha Kim
doaj +1 more source
Polypharmacy as an Independent Risk Factor For Serious Adverse Drug Reactions - A Systematic Review
, 2021 Rita Bárbara Cardoso Gomes
openalex +1 more source
Diabetes, Obesity and Metabolism, EarlyView.Abstract Background Older adults with type 2 diabetes (T2DM) are less likely to receive sodium–glucose cotransporter‐2 (SGLT2) inhibitors, despite their proven cardio‐renal benefits and safety. Whether this age‐related gap is driven by frailty, sex, or other factors remains unclear.
Changyuan Yang +6 more
wiley +1 more source